Great article, and shows the massive earnings and licensing potential for Zantrene to be sold as Individual Combined Formulations to each and every Drug maker as a method to extend each of those patents.
Maybe Zantrene can become the Paracetamol of Oncology, where nearly every Cancer treatment includes a base dose of Zantrene to boost Efficiency and Safety!
Great article, and shows the massive earnings and licensing...
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.24 |
Change
-0.020(1.59%) |
Mkt cap ! $205.2M | |||
| Open | High | Low | Value | Volume |
| $1.26 | $1.26 | $1.21 | $80.80K | 65.48K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4453 | $1.24 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.25 | 2409 | 1 |
View Market Depth
| Last trade - 16.10pm 01/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.24 |
Change
-0.020 ( 1.59 %) |
||||
| Open | High | Low | Volume | ||
| $1.25 | $1.25 | $1.21 | 17239 | ||
| Last updated 15.56pm 01/05/2024 ? | |||||
| RAC (ASX) Chart |